We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Anthera Lupus Trial Back on Following Investigation
Anthera Lupus Trial Back on Following Investigation
January 6, 2011
Anthera plans to reinitiate enrollment in its suspended Phase IIb lupus drug trial this month after an investigation determined cracks found in vials of the drug, A-623, were likely caused by extreme cold during transport.